IP Library Granted Patent US 7,306,908
Granted Patent B2
US 7,306,908 · App. 10/415,247 · Granted Dec 11, 2007

Nucleic acids associated with rheumatoid arthritis, and methods and kits for the diagnosis thereof

Assignee: Shunichi Shiozawa
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,306,908
App. No.
10/415,247
Granted
Dec 11, 2007
Kind
B2
Abstract

Mutations in a genome associating in rheumatoid arthritis (RA) are found in human DR3 genomic DNA having the base sequence represented by SEQ ID NO:1. The invention provides a genome having such mutations, transcripts thereof, a method of highly accurately evaluating the RA onset or the RA onset possibility by using the mutations thereof, an evaluation kit therefor, and a therapeutic method and remedies for RA.

Claims (6)

1. A purified nucleic acid associated with rheumatoid arthritis comprising the nucleotide sequence of SEQ ID NO:1 having the following mutation:

an adenine (A) to thymine (T) substitution at position 2678.

2. A method of evaluating onset or onset possibility of rheumatoid arthritis in a human subject, comprising the step of detecting in a human subject a nucleic acid associated with rheumatoid arthritis comprising the nucleotide sequence of SEQ ID NO:1 having the following mutation:

an adenine (A) to thymine (T) substitution at position 2678, wherein detection of said nucleic acid is indicative of the possibility of the onset of rheumatoid arthritis in the subject.

3. A method of evaluating onset or onset possibility of rheumatoid arthritis in a human subject, comprising the step of detecting in a human subject the presence of a mutation in a nucleic acid associated with rheumatoid arthritis wherein the nucleic acid comprises the nucleotide sequence of SEQ ID NO:1, and wherein said mutation is an adenine (A) to thymine (T) substitution at position 2678 in SEQ ID NO:1, wherein the presence of the mutation in the nucleic acid is indicative of the possibility of the onset of rheumatoid arthritis in the subject.

4. A kit for evaluating the onset or onset possibility of rheumatoid arthritis in a human subject, the kit comprising a reagent comprising the nucleotide sequence of SEQ ID NO:1 having an adenine (A) to thymine (T) substitution at position 2678; or a nucleic acid fully complementary to said nucleotide sequence of SEQ ID NO:1 having the adenine (A) to thymine (T) substitution at position 2678.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2003
From: SHIOZAWA, SHUNICHI; KONISHI, YOSHITAKE
To: SHIOZAWA, SHUNICHI
Reel/Frame 014397/0919 →
Priority Claims (3)
JP 2000-324296 · Oct 24, 2000 · national
JP 2001-090546 · Mar 27, 2001 · national
JP 2001-099990 · Mar 30, 2001 · national
Continuity (1)
Related Publication 20040013655A1 · Jan 22, 2004